Directory · CA
Biotechnology in Canada
A register of firms and the professionals working at them in the Biotechnology sector based in Canada. Browse the public index, then filter or export on Kipplo.
Companies
245 on file
Biovectra
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Biologics Synthetic small molecules Fermented small molecules Highly potent APIs Bioreagents mRNA, pDNA, LNP manufacturing Fill/Finish Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
501 to 1000 staff
Acadian Seaplants
Acadian Seaplants is a seaweed and food-supply chain company that provides plants, animals and people with sustainable sources of essential nutrients and organic compounds. We began as a family-owned seaweed company nestled in the heart of Atlantic Canada. Our vision, our passionate people and an incredible renewable resource carried us onto the global stage. Now, we offer sustainable, high-quality and research-based solutions in over 80 countries that satisfy the vital needs of plants, animals and people.
201 to 500 staff
Canam Bioresearch Inc
CanAm Bioresearch is a well-established North American based medicinal chemistry Contract Research Organization (CRO) with more than 20 years of experience in drug discovery. We have a long history working with start-ups and spin-outs worldwide and providing discounts and flexible payment arrangements during the pre-seed and seed funding stages of the company life cycle. Our team excels in medicinal chemistry, custom chemical synthesis and analytical services. Our highly skilled team of organic and medicinal PhD chemists have the knowledge and experience to resolve various challenges, delivering high quality results in a timely manner. We specialize in synthetic organic chemistry to support SAR of drug discovery programs at the hit-to-lead and lead optimization stages, including scale-up batches to enable early toxicology studies. We also offer chemical library synthesis, custom organic synthesis, and analytical services (including HPLC-UV and LC-MS analysis, purity analysis and process monitoring, stability and solubility determinations). Additionally, we can manage fully integrated pre-clinical ADME/PK profiling assays. Our research facility is fully equipped with all the instruments for efficient organic synthesis and analysis (including microwave reactors, automated purification systems, multinuclear NMR, mass spectrometers, analytical and semi-preparative HPLCs, and LC-MS/MS units dedicated to ADME analysis). Each chemist involved in your project is a PhD skilled in the art of medicinal chemistry and organic synthesis and presents progress reports directly to you at regular meetings. The chemists working at the bench on your project are always accessible to you and act as your in-house research team.
11 to 50 staff
K' Prime Technologies Inc
K′(Prime) Technologies Inc. or K′(Prime) is a global imaging services company headquartered in Calgary, Alberta, and wholly owned by Nanalysis Scientific Corp.(TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1). K′(Prime)’s capabilities encompass chemistry, commercial security, sales of scientific instruments, and airport imaging services, including X-ray and millimetre wave imaging. K'(Prime)'s mission is to redefine imaging security across Canada and the world through continuous innovation, data-driven insights, and trusted partnerships—empowering safer, smarter environments for tomorrow. Our vision is to lead Canada in imaging security innovation—delivering expertise globally in installation, consultation, maintenance, sales, and optimization of advanced systems that protect people, assets, and infrastructure with intelligence and reliability. K'(Prime) is Canada’s Imaging Security Leader—Delivering What Others Can’t 1. Nationwide Responsiveness Coast-to-coast coverage—ready to respond within hours, where others can’t. Cross-Functional Expertise Situation-ready teams with deep technical and operational knowledge to solve complex challenges and ensure regulatory compliance. Strategic Parts Availability A robust distribution network ensures minimal downtime—clients stay operational, even under pressure. Dependability When It Matters Most The trusted choice when others fall short—clients call us when they’ve been left stranded. Customer-Centric Performance We protect our clients’ bottom line. Their success is our success—driven by up-time, reliability, and peace of mind.
51 to 200 staff
Nod Apiary Products Ltd
NOD Apiary Products Ltd. is a Canadian company formed in 1997 by beekeepers in Canada. Honeybee and animal health is our focus. The founders at NOD saw formic acid as the active ingredient most likely to be developed into a practical, sustainable miticide for the beekeeping industry. Properly formulated, it could control varroa, tracheal and tropilaelaps mites, protect the image of honey as a wholesome food, and leave no residues in the hive components. NOD Apiary Products Ltd. continues to aid the developing apiculture industry by producing organic and sustainable Honey bee health products. Formic Pro™ and the Mite Away Quick Strips (MAQS Beehive Strips) are formic acid polysaccharide gel strips which, when placed in the brood chamber of a honey bee hive, act as an organic miticide that kills the varroa mite where it reproduces, under the brood cap. The Formic Pro™ and MAQS™ technology eliminates the risk of residues; beekeepers can use it safely during the honey flow. Formic Pro™ and Mite Away Quick Strips (MAQS Beehive Strips) are registered in several countries across Europe, and in Canada, The United States, and New Zealand. NOD Apiary Products’ Bee Cozy Winter Hive Wraps have been used successfully in the field for over 25 years. By properly preparing Honey bees for winter, colonies consume less feed stores and reach maximum health and vigour earlier in the season. Easy to work with, the Bee Cozy ‘slip-on, slip-off’ system saves beekeepers valuable time getting ready for winter. NOD Apiary Products’ focus on honey bee health expanded when the dairy farmers on our team discovered that organic acids, like formic acid, could also be used for livestock. The Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) research on Acidified Milk Feeding Programs for the dairy cow, goat and sheep industries inspired NOD employees to investigate. The results were very positive and we launched the newest addition to our product line, Nature’s Way 9.8™.
11 to 50 staff
Biodextris
Follow us for the latest on our expansion, job opportunities and the latest relevant news in our space! Biodextris is comprised of experienced product development scientist located in Laval (Montreal), Quebec. The group has worked together since 2002, as part of ID Biomedical and later GSK-Vaccines. We have developed numerous products for all phases of clinical development for programs conducted in the US, Canada and Europe. Companies choose to work with us because we are experts in developing complete analytical packages for novel and complex products. Companies trust us to accelerate their project from the bench to the clinic by delivering robust and reliable production processes ready for manufacturing. Companies rely on our Quality Control testing services for their clinical phase vaccines and biologics. We look forward to sharing this expertise with you.
11 to 50 staff
Ceapro
Ceapro Inc. is a Canadian biotechnology company involved in the development and commercialization of “active ingredients” derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. Ceapro’s patented process technologies include its Pressurized Gas eXpanded (PGX) technology which is a unique and disruptive technology with several key advantages over conventional drying and purification methods that can be used to process biopolymers into high-value, nano-sized polymer structures and novel bio-nanocomposites. Ceapro also utilizes its proprietary plant extraction-based manufacturing process to supply ingredients to well-known personal care and cosmetic industries worldwide. The Company’s two value-driving products, oat beta glucan and avenanthramides, are found in many household names, cosmetic and personal care brands. These products are manufactured from Ceapro’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Oat beta glucan effectively stimulates collagen synthesis and deeply moisturizes the skin (epidermis and dermis) thereby improving skin restructuring, decreasing wrinkles and allowing wound healing with minimal scaring. When taken orally, oat beta glucan has been shown to improve cholesterol levels and therefore has “heart health” approved health claims in Canada, United States and Europe. Avenanthramides are polyphenolic compounds found exclusively in oats which act as natural anti-oxidant, anti-irritant and anti-inflammatory. When added to topical formulation, avenanthramides effectively reduce redness and itchiness due to inflammation. In oral formulations, avenanthramides could treat serious conditions triggered by inflammation. Given the therapeutic benefits of the Company’s two flagship products, Ceapro is currently expanding and developing them for use in the nutraceutical industries.
11 to 50 staff
Nicoya
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, is capable of accelerating drug discovery using a fraction of sample volume traditionally required for biomolecular interaction analyses. Alto helps biotechnology and pharmaceutical companies go-to-market faster with increased efficiency and success early in their product pipelines. Join us on our mission to improve human life by helping scientists to succeed. For job opportunities, see our webpage at https://nicoyalife.com/about/careers/
51 to 200 staff
Sernova
Sernova (TSX: SVA)(OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing its implantable Cell Pouch™ bio-hybrid organ which works to restore the body’s normal function so that people with type 1 diabetes (T1D) and other chronic diseases can focus on what matters most: living their lives.
11 to 50 staff
Biena
We are a Canadian company specializing in the production of probiotic strains, starters, and ripening cultures. Our mission is to collaborate with you to develop innovative and effective solutions that meet your growth objectives. Our m² state-of-the-art cGMP production facility houses all of our departments, allowing us to create outstanding products that meet FDA, Halal, Non-GMO Project Verified, ID Verified, and cGMP certifications. Nous sommes une entreprise canadienne spécialisée dans la production de souches probiotiques et de ferments d’acidification & d’affinage. Notre mission est de collaborer avec vous pour développer des solutions innovatrices et efficaces qui répondent à vos objectifs de croissance. Nos m² d'installations cGMP à la fine pointe de la technologie, regroupent tous nos départements afin de créer des produits exceptionnels qui répondent aux certifications FDA, Halal, Non-GMO Project Verified, ID Verified, et cGMP.
51 to 200 staff
Custom Biologics
Custom Biologics is a regulatory compliant large molecule bioanalytical CRO specializing in the potency assessment and clinical testing of biologic-based drugs, vaccine, and gene therapy products. Our scientists and quality assurance team provides exceptional, high quality, customized assays to measure the functional properties of cellular and biotherapeutic drug candidates. We are a Health Canada audited, GMP-compliant, global service provider for functional testing of biotherapeutics, biosimilars and antibody drug conjugates. For nearly 20 years, our scientists have been designing and validating sophisticated bioanalytical assays to characterize and measure the therapeutic potential of large and small molecule biotherapeutics. Our work supports regulatory drug submission applications from biopharmaceutical companies throughout North America, Europe and Asia. Great Science - It's at the heart of everything we do!
11 to 50 staff
Geneseeq Technology Inc
Geneseeq Technology Inc. is a research-driven global leader in precision oncology, advancing cancer detection, diagnosis, and treatment through cutting-edge next-generation sequencing (NGS) technologies. With headquarters in Canada and China, Geneseeq operates CAP, CLIA, and ISO 15189-accredited laboratories for central laboratory testing, and is ISO 13485-certified for the development and manufacturing of both in vitro diagnostic (IVD) and research use only (RUO) testing kits. Our comprehensive testing portfolio includes-Pan-cancer panels covering over 400 genes-Cancer-type-specific panels tailored for solid tumors and hematologic malignancies-Minimal residual disease (MRD) monitoring technologies-Multi-cancer early detection (MCED) solutions, including CanScan®, which holds both CE mark and FDA Breakthrough Device Designation-CE-IVD and NMPA-approved NGS-based assays, including tumor mutational burden (TMB) testing. Geneseeq’s testing services and products are widely adopted by more than oncologist partners across 20+ countries and regions. We are actively involved in over 2,700 research collaborations with pharmaceutical and academic partners, providing high-quality genomic data to support biomarker discovery, clinical development, and translational research. Driven by innovation and a commitment to quality, Geneseeq delivers integrated NGS solutions that help guide personalized treatment decisions and accelerate the global adoption of precision cancer care.
1001 to 5000 staff
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows us to maintain our leadership position in the space. • Best-in-class LNP + next generation ligand conjugate technologies • First and only FDA-approved siRNA-LNP utilizes Genevant technology • Nucleic acid payload design expertise • Several hundred patents worldwide • LNP technology evaluated in more than a dozen clinical programs, representing hundreds of subjects and patients • An established leader in delivery to the liver, now focusing capabilities on other tissues and cell types • Experienced team with deep technical expertise and a track record of innovation and creative corporate partnering
11 to 50 staff
Mrm Proteomics Inc
MRM Proteomics is at the leading edge of precision proteomics technology. We offer a wide range of proteomics services and easy-to-use kits. We are also involved in developing clinical diagnostics. Our mission is to offer the highest quality of proteomics technologies on the market today. We also offer unique custom-tailored solutions for specific research projects. Our technology advantages include: MRM-MS with paired heavy/light peptide standards for high-precision highly-multiplexed quantitation of hundreds of proteins; Patented iMALDI-MS technology for robust high-throughput clinical proteomics; High-resolution HDX structural characterization of proteins and biosimilars; and Tissue imaging of peptides and lipids using innovative techniques (patent pending)
11 to 50 staff
Northern Rna Inc
We are a Canadian CDMO specializing in the production of nucleic acid products that support life-enabling work. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.
51 to 200 staff
Acuitas Therapeutics
Acuitas is the premier LNP (lipid nanoparticle) technology provider, enabling our partners to advance new therapeutics to address unmet clinical needs. We have developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics. Our mission is · To provide our partners with the best LNP delivery technology for nucleic acid therapeutics · To support our partners to rapidly advance new therapeutics to address unmet medical needs · To continually innovate to maintain and strengthen our LNP technological lead Acuitas partners locally and globally with companies, academic institutes and other organizations to improve human health.
51 to 200 staff
Avivo Biomedical Inc
Avivo, a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. This innovative platform enables a world where a person’s blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions. Avivo’s platform will enable healthcare providers to better prioritize patients by medical urgency, spend less on management and logistics and ultimately save more lives.
1 to 10 staff
Cannapiece Corp
CannaPiece Corp is a global leader in cannabinoid processing and manufacturing, seeking to establish new standards in the global cannabis industry. We have services and products to cover the gaps in the current supply chain, including; R&D, Product Development, Third-Party Processing, Packaging, Large-Scale Extraction, Production of Edibles, Topicals and Concentrates as well as White-Labeled products to both Domestic and International markets. We strive to be one of the most trusted and reliable manufacturing facilities globally.
51 to 200 staff
Itr Laboratories Canada Inc
ITR Canada provides preclinical testing services for the pharmaceutical and biotechnology industries. Since our founding in 1989 we have grown into a mid-sized Contract Research Organization (CRO). As a CRO with extensive experience, we provide you with valuable input and best practices, which ultimately help you maximize the value of your research investment. We deliver on time project reporting that meets your company’s goals. ITR Canada offre des services d’essais précliniques pour les industries pharmaceutiques et de biotechnologie. Depuis notre création en 1989, nous nous sommes développée en une organisation de recherche contractuelle (CRO) de taille moyenne grandissante. En tant que CRO avec une vaste expérience, nous vous fournissons une contribution valable et les meilleures pratiques disponibles, qui vous aident finalement à optimiser la valeur de votre investissement en recherche. Nous vous livrons des rapports de projet en temps voulu et qui répondent aux objectifs de votre entreprise.
201 to 500 staff
Life Sciences Bc
Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
1 to 10 staff
Ubrigene Biosciences Inc
uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.
11 to 50 staff
48hour Discovery
Founded in 2017, 48Hour Discovery (48HD) has a powerful technology platform for peptide-based drug discovery. We are reducing the cost, time, and risk of developing new therapies with our innovative target screening strategy to quickly identify the best and most promising drug leads.
11 to 50 staff
Advanced Electrophoresis Solutions Ltd. Aes
Advanced Electrophoresis Solutions Ltd.(AES) is committed to offering comprehensive solutions in whole-column imaging detection capillary isoelectric focusing (WCID-iCIEF). Specializing in system development, we also provide customized critical reagents tailored to Fusion proteins, Antibody-Drug Conjugates (ADCs), monoclonal antibodies (mAbs), and more. Additionally, AES supplies an extensive range of consumables, ensuring a complete offering for our clients' diverse needs.
11 to 50 staff
Allarta Life Science Inc
A pre-clinical regenerative medicine company building transformative platform technology to deliver cells and stem cells to patients world-wide.
11 to 50 staff
Blueweight
For all the Aquaculture Farmers and Dealers worldwide, we provide biotechnological solutions to Problems like Microcystis, Turbidity, Dinoflagellates, Vibrio control.
51 to 200 staff
Crbm - Centre De Recherche Sur Les Biotechnologies Marines
Le CRBM se définit par une vocation de recherche et développement (R-D) orientée et appliquée ainsi que de services de recherche industrielle en biotechnologies. Le CRBM agit à titre d’organisation intermédiaire et d’arrimage entre les institutions universitaires et les entreprises privées en assurant des activités de recherche et transfert en entreprise pour différents secteurs de marché. De plus, le CRBM offre une approche d’encadrement technologique et scientifique pour compléter les besoins déjà disponibles en accompagnement d’affaires des entreprises. The CRBM fulfills R&D mandates on the processing of marine biomass products for biotechnology applications, the development of added value products, the analysis of extracts and molecules, the development and optimization of industrial processes, the development of quality control systems and the assessment and development of products.
11 to 50 staff
Diamentis
Founded in Quebec City in 2015, diaMentis is the first company to develop a software as medical device (SaMD) that analyses information from a simple examination of the eye (electroretinography). Mission: Develop, valorise, patent and market (directly or indirectly) a diagnostic tool for better management of patients with mental disorders in a personalised healthcare environment. diaMentis value proposition: • A non-invasive, not expensive and easy to implement test • A reliable method of analysis • Fast results via a centralized service diaMentis technology will lead to: • More accurate and faster diagnosis • Appropriate choice of treatments and psychotherapy • Better acceptance of the disease by the patient and better monitoring of treatments • Reduction in relapses • Decrease in duration and number of hospitalizations • Return to work faster (reduction of disability premiums and family pressure)
11 to 50 staff
Earth Alive Clean Technologies
Life science at the service of the earth, Earth Alive is a biotech addressing environmental challenges in agriculture, mining and industry with a portfolio of innovative and effective biological technologies and living microorganisms. We are leaders in the development, production and distribution of technological solutions that are shifting industry from the chemical to the biological era.
11 to 50 staff
Igem Toronto
iGEM (International Genetically Engineered Machine)Toronto is an interdisciplinary team that identifies problems in our community, proposes and executes a synthetic biology-based solution. We are dedicated to the practice of biotechnology and the dissemination of its scientific foundations. The culmination of each year's efforts is a submission to the iGEM conference (Grand Jamboree), representing the University of Toronto.
51 to 200 staff
Imv Inc
IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform: the DPX® technology. Through a differentiated mechanism of action, the DPX® platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. IMV’s lead candidate, maveropepimut-S (MVP-S), delivers antigenic peptides of survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers. MVP-S treatment has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. MVP-S is currently being evaluated in clinical trials for hematologic and solid cancers, including Diffuse Large B Cell Lymphoma (DLBCL) as well as ovarian, bladder and breast cancers. For more information, please connect at:
51 to 200 staff
Jmcc Group
JMCC Group is the leading global provider of premium quality, sustainably grown, medical cannabis and psilocybin products and related services to customers around the world, including licensed producers, medical researchers, product developers, manufacturers and distributors. Our JMCC Source division combines Jamaica’s unique cannabis varieties and its optimal growing climate to produce the safest, most natural raw product possible to global quality standards for botanical medical ingredients. JMCC Scientific develops and produces cannabis-based treatments for a variety of conditions, including pain, anxiety and MS spasticity, under the guidance of leading medical specialists, who also guide JMCC’s participation in medical research initiatives worldwide. These include Project Twenty21 in the United Kingdom, Europe’s largest national medical cannabis registry, involving patients by the end of 2021. JMCC Distribution gets our medical cannabis products and those of our distribution-services clients, to customers and research partners worldwide swiftly, securely and safely. Leveraging best practices, global scale, and long-standing relationships with leading transportation companies worldwide, JMCC Distribution encompasses our proprietary, state-of-the-art warehouse management system and GDP-compliant distribution centres in Jamaica, Australia and the EU to provide a seamless customer experience and eliminate supply interruptions for patients. Collaboration is key to building a successful, socially responsible medical cannabis industry. We work with a variety of partners, including the members of our Farmers’ Collective and other growers’ associations in Jamaica, medical research entities, cannabis industry groups, patient advocacy and public education organizations. Together, we’re striving to build a world where the benefits of medical cannabis are scientifically proven and available to all. Where Nature Meets Science.™
11 to 50 staff
Koonkie
We work with data from all over the planet (with implications beyond). We’ve helped find therapeutic targets, kick-start environmental recovery and reclamation, discover new species, and uncover life's strategy for survival on distant planets. Our team of highly trained scientists, computational experts, and biologists capture value and biological insights from your data. We offer custom bioinformatic pipelines, build algorithmic and software solutions, manage workflows to better communicate your data's power, and - most importantly - interpret your data. Reach out today to capture, tame, and learn how to manage your Big wild (genomic) Data.
1 to 10 staff
Neova Technologies Inc
Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service. Neova takes an integrated approach to product development and quality enhancement. With a strong history in research and development to support the products we sell, our approach is to seek practical solutions that regularly challenge current limits and assumptions. Neova’s strong team of researchers understand the functionality that our products can bring to the different industries and applications that our customers represent. Some research projects are undertaken with the objective of publication for the benefit of industry, while others are carried out for the benefit of a single customer. Regardless, the same systematic approach to the research applies. In addition, our customers are critical in establishing market needs and identifying opportunities. We take a collaborative approach and work with our customers to identify new products and applications. A third critical partner in research and product development is our operations and production group. This group is involved throughout the product design and improvement process, ensuring that the product the customer needs can be delivered consistently, meeting the specifications the customer requires. The results: Neova delivers solutions that are custom-designed to meet the needs of our customers. A rigorous approach to research and a strong quality-centered operational environment ensures that quality is not compromised for speed or expense. Neova Technologies Inc. is a Bioseutica Group company. The production facilities are located in Abbotsford BC Canada. The equipment is strategically placed at processing facilities in order to guarantee continuous access to fresh, traceable raw material and to enhance logistics and cost savings.The production process follows GMP guidelines. Neova Technologies Inc. holds GMP certification for production of active pharmaceutical ingredients as well as Halal and Kosher certifications for compliant food solutions. Functional food ingredients and diagnostic media that can be used for cell and tissue culture purpose or for development of nutraceutical products and infant formulas. Functional Food Ingredients OTC biopharma and Nutraceuticals Diagnostic and Research Media
51 to 200 staff
Nono Inc
NoNO Inc. is a clinical-stage biotherapeutics company dedicated to the research and development of pharmaceuticals for the treatment of common health disorders with unmet needs, including acute ischemic stroke.
11 to 50 staff
Reddot Biotech Inc
We focus on providing customers in the global marketplace with timely customer service, reliable supply, and products with superior quality and performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sales of ELISA kits for pharmaceutical, laboratory, medical and scientific research use. We currently provide more than different kinds of ELISA kits. We are committed to R&D to bring customers top quality products providing accurate, reliable and fast results. With extensive experience working with companies and research institutes across the world, we offer tremendous value in the service and products we provide.
1 to 10 staff
Rose Scientific Ltd
Rose Scientific Ltd is a global distributor in providing laboratory products, services, and solutions to the life sciences, biotechnology, pharmaceutical, and industrial sectors. With over thirty years of experience, we offer a comprehensive portfolio of high-quality laboratory supplies, chemicals, equipment, and services that enable customers to accelerate scientific discovery and enhance productivity. We offer a carefully curated selection of advanced scientific instruments from leading global manufacturers, complemented by exceptional technical support and customer service. Our expert team collaborates closely with clients to understand their unique requirements, ensuring they have access to the right tools for research, analysis, and operational needs. At Rose Scientific, we are committed to building long-lasting relationships with our customers, helping them achieve their goals with precision, reliability, and excellence. Whether in the laboratory, university, or field, we are here to provide the equipment and expertise that drive tomorrow’s breakthroughs. Rose Scientific's portfolio also features a range of OEM products, which we distribute through our global network. We stay informed on the latest scientific advancements by actively participating in both local and international scientific conferences.
1 to 10 staff
Amacathera
At AmacaThera we are the leading developer of next-generation hydrogel-based drug delivery solutions. Using our proprietary blend of known polymers, our clinically validated hydrogel platform is transforming drug delivery by enabling the precise, tunable, and sustained release of a wide range of therapeutics, from small molecules to biologics. By transforming liquid to gel at body temperature, our hydrogel enables drugs to be delivered to and stay precisely where they are needed and released over days or weeks, depending on the specific needs of each therapeutic application. Building on this foundation, we are leveraging our proprietary hydrogel platform to co-develop innovative drug delivery solutions with pharmaceutical and biotechnology partners. The platform’s inherent versatility enables the creation of long-acting formulations that enhance therapeutic efficacy, improve patient convenience, and minimize systemic exposure. Scalable and cost-effective to manufacture, our hydrogel technology supports a collaborative business model designed to deliver value across a broad range of therapeutic areas and product modalities.
1 to 10 staff
Dispersa
Transforming food waste into sustainable, circular biosurfactants for the first time on the global market. Our biosurfactants are not only palm and petroleum-free, but also crafted using food waste instead of food-grade sources used in existing biosurfactants. Dispersa’s goal is to offer greater sustainability & affordability within the biosurfactant market.
11 to 50 staff
Eupraxia Pharmaceuticals Inc
Eupraxia Pharmaceuticals is a public, clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the Diffusphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's Diffusphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.
11 to 50 staff
Geneyouin Inc
Founded in 2012, GeneYouIn, the provider of Pillcheck, helps individuals and their healthcare providers choose the right medications to feel better sooner. Many health plans partner with Pillcheck to bring the positive health impacts of precision medicine to their members. Pillcheck was the first platform combining DNA analysis with clinical pharmacy services, and we remain leaders in the field. We operate in North America and Europe, complying with healthcare and data privacy regulations globally. Our multi-lingual software-enabled service integrates expert pharmacist reviews and delivers the consistent application of precision medicine insights for individuals, businesses, and healthcare providers. Pillcheck’s technology architecture addresses the demand for rapid deployment, flexible configuration, and evolving precision medicine programs over time based on data analysis. The Pillcheck platform automates the analysis of genetic data. It includes an auditable gateway for managing genetic and drug-reference information. In addition, the secure front-end web application facilitates role-based access for the provision of reliable DNA-guided prescribing. Clinical diagnostic laboratories in the US, Canada and Europe have independently validated our bioinformatics system. We partner only with certified clinical genetic laboratories.
1 to 10 staff
Htuo Biosciences
HTuO Biosciences is a deep tech company, working at the interface of chemistry, physics and computer programming, to develop an advanced molecular simulation capable of accurately predicting the behaviour of molecules.
1 to 10 staff
Index Bio
Index has created the first unified predictive food safety platform. Enabled by BioTags®, we simulate contamination risk and expedite crisis response. BioTags® are inert (not-living), uniquely identifiable microbes applied directly to goods and the environment. BioTags are authorized for use in food by Health Canada and the FDA.
1 to 10 staff
Qualisure Diagnostics Inc
Qualisure Diagnostics Inc. develops molecular diagnostic tests that enhance cancer care through early detection, improving diagnostic precision, and facilitating individualization of treatments. Our biomarkers and algorithms are designed to make cancer screening easier and more convenient for the patient; to guide decision making for oncologists; and to drive cost savings for the healthcare system. Each of our biomarkers is designed to influence clinical decision making and to facilitate Precision Medicine.
1 to 10 staff
Tersa Earth
We are a Vancouver, Canada-based solutions-provider for the mining industry, targeting the treatment of acid rock drainage (ARD), reducing the carbon intensity of mining waste remediation and advancing metals recovery.
1 to 10 staff
Biologic Pharmamedical Research
BIOLOGIC PHARMAMEDICAL RESEARCH & MANUFACTURING RESEARCHING LIFE-CHANGING SOLUTIONS REINGINEERING THE POWER OF NATURE REINVENTING YOUR HEALTH CATEGORY REPOSITIONING YOU AS A BRAND LEADER Welcome to Biologic Pharmamedical Research & Manufacturing, where we specialize in helping leading supplement brands create unique and high-end nutraceutical products that are differentiated and protected by patents and published research that leverages our scientific expertise and custom manufacturing services from the R&D stage to marketing. Franco Cavaleri, is a Biomedical Researcher in Experimental Medicine & Disease Pathology; Best Selling Author and Former IFBB Mr. North America. Cavaleri and his team use scientific principles to standardize common categories, generating peer-reviewed research papers that can be leveraged for marketing and the creation of innovative and proven nutraceutical products for discerning, health-conscious consumers. This approach allows us to reinvent supplement categories, delivering new levels of efficacy and distinguishing our clients as unique brands in the market. We offer custom formulation and manufacturing services for finished natural products, helping our clients gain a competitive edge in a busy market. Our patented, researched ingredients are differentiated through peer-reviewed scientific papers and articles, allowing our clients to stand out in their respective categories. At Biologic Pharmamedical Research & Manufacturing, we pride ourselves on our ability to discover novel remedies from age-old natural ingredients, reimagining them into efficacious ingredients that customers can feel working immediately. This is key: results experienced within minutes! We're passionate about researching life-changing solutions, reengineering the power of nature, and reinventing our clients' health categories. Let us help you position yourself as a product leader in the supplement industry. Contact us today to learn more about our custom m
1 to 10 staff
Bvt - Bee Vectoring Technologies
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT’s award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides – and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide, and has US EPA registration of its VECTORITE™ with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops. Additional information can be viewed at the Company’s website To receive regular news updates from the Company, subscribe at
1 to 10 staff
Flow Scientific Ltd
Flow Scientific Ltd. is the premier Canadian manufacturer of naturally sourced, high-quality terpenes. Inspired by common cannabis strains, fruit blends, and isolated terpenes. The Flow team of chemists has developed products that are relevant to the emerging cannabis markets locally and globally such as extracts, vape cartridges, beverages, edibles, and topicals. All Flow products are fully compliant and come with a COA, Bill of Materials, and a safety data sheet. We don't use any PG, VG, PEG, MCT or vitamin E. linktr.ee/flowscientific
11 to 50 staff
Integrated Nanotherapeutics Inc
Integrated Nanotherapeutics Inc (INT) is a preclinical company developing antigen specific immune tolerance therapies using mRNA-Lipid nanoParticles (LNP). We have demonstrated that our mRNA-LNP therapy can reverse Type 1 Diabetes (T1D) in NOD mice. We were recently awarded a grant from Breakthrough T1D (formerly JDRF). With a growing pipeline in other T-cell-driven autoimmune diseases, we have successfully demonstrated in additional animal models that our tolerizing-LNP induces antigen-specific immune tolerance. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies. We leverage this inherent capability of our platform technology to achieve antigen specific immune tolerance. We can deliver multiple antigens or epitopes due to the simplicity of using mRNA to express them. Additionally, we modify the immune response phenotype to these antigens by incorporating small-molecule immune modulators within the same LNP package.
11 to 50 staff
